RESOLUTE 5-Year Outcomes:
Excellent Long Term Results with Resolute

RESOLUTE 5-year data show very low event rates

TLR Rates
3.1% TLR rate at 5 years

TLR at 5 Years

1Missing data on one patient, n = 129

 

ARC Def/Prob ST Rates
0% ST rate at 5 years

ARC Def/Prob ST at 5 Years

*n=129, missing data from one patient.
RESOLUTE had single de novo native coronary artery lesions. Lesion length: 14–27 mm. Stent diameters: 2.5, 3.0, 3.5 mm. Stent lengths: 18, 24, 30 mm (8/9 mm bailout).

Trial Design

RESOLUTE PI: I. Meredith

RESOLUTE Trial Design

 

High Percentage of Challenging Cases in RESOLUTE Trial

High Percentage of Challenging Cases in RESOLUTE Trial

Device success: <50% residual in-stent % DS with assigned stent.
Procedure success: <50% residual in-stent % DS & without in-hospital MACE.

Resolute Integrity Zotarolimus-Eluting Coronary Stent System

Now Available in 34 and 38mm Lengths

Email Page

Send a link to this page by email along with your comments.
Please enter the information below.

  1. (required)
  2. (required)
  3. (required)